BioMedTracker

Event Alerts

Date	Lead Company	Event	Type	Approval Change	Approval Likelihood
02/03/12	Talon Therapeutics (TLON)	Marqibo for Acute Lymphocytic Leukemia (ALL)	Subscribers Only	Subscribers Only	Subscribers Only
02/03/12	Exelixis (EXEL)	Cabozantinib for Renal Cell Cancer (RCC)	Subscribers Only	Subscribers Only	Subscribers Only
02/03/12	Threshold Pharma (THLD)	TH-302 for Sarcoma	Subscribers Only	Subscribers Only	Subscribers Only
02/02/12	Merck (MRK)	Janumet XR for Diabetes Mellitus, Type II	Subscribers Only	Subscribers Only	Subscribers Only
02/02/12	Merck (MRK)	Dulera for Chronic Obstructive Pulmonary Disease (COPD)	Subscribers Only	Subscribers Only	Subscribers Only
More...

	Expected Date Range	Lead Company	Drug	Expected Catalyst
	02/06/12	Subscribers Only	Subscribers Only	Company - Earnings Announcement
	Now - 02/07/12	Subscribers Only	Subscribers Only	Regulatory - J-NDA Filing (Japan)
	Now - 02/07/12	Subscribers Only	Subscribers Only	Company - Earnings Announcement
	Now - 02/07/12	Subscribers Only	Subscribers Only	Company - Earnings Announcement
	Now - 02/07/12	Subscribers Only	Subscribers Only	Company - Earnings Announcement
More...

01/04/12	Nature Reviews Drug Discovery - 2011 in reflection (subscription required)
01/03/12	Nature Reviews Drug Discovery - Market Watch: Upcoming Market Catalysts in Q1 2012
11/15/11	SF Chronicle/Bloomberg News - Corporate venture funds boost biotech startups
10/26/11	SF Business Times - Biotech's new normal: Innovation but no VC money, risk More...